Markets

Health Care Sector Update for 09/05/2017: ATRA

A generic image of a pen on a chart
Credit: Shutterstock photo

Top Health-care stocks:

JNJ: flat

PFE: -0.3%

ABT: flat

MRK: flat

AMGN: flat

Health-care shares were mainly unchanged in pre-market trade Tuesday.

In health-care stocks news, Atara Biotherapeutics ( ATRA ) said Tuesday that its ATA230 has been granted orphan drug designation for the treatment of cytomegalovirus (CMV) viremia and disease in immunocompromised patients by the U.S. Food and Drug Administration.

Shares in the company were unchanged at $15.25 in early trade. The stock has traded between $11.80 and $23 over the past 52 weeks.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ATRA

Other Topics

US Markets

Latest Markets Videos

    MTNewswires

    Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

    Learn More